Ten years ago, a 73 year-old patient presented at our unit with a right nephritic colic and elevated serum creatinine (2.1 mg/dl). This was the first time that the patient had consulted for a urology workup. An abdominal X-ray was performed in which we observed a severe bilateral nephrocalcinosis with right ureteral lithiasis. One of the causes of nephrocalcinosis is distal renal tubular acidosis (dRTA), in that sense the patient presented metabolic acidosis (pH 7.25) together with normopotassaemia (4.4 meq/L) and normochlorine (105 mEq/L). A 24-hour urine test detected citrate (55 mg/dl), calcium (12 mg/dl) and pH of 6.5. A diuretic renogram showed the right relative renal function as 91.2% and left relative renal function as 8.8%. A test with bicarbonate and acetazolamide was performed, confirming a diagnosis of dRTA because the urinary CO2 pressure was 32 mmHg (normal, greater than 70 mmHg). Treatment with potassium citrate and increased intake of liquids was prescribed. Consequently, the patient's serum creatinine normalized, her blood pH rose to 7.35 and urinary citrate increased to 154 mg/dl. After 10 years of treatment with potassium citrate the patient remains stable. We believe that in these patients it is crucial to carry out an alkalizing treatment: patients with dRTA cannot acidify the urine because a defect in the permeability of the tubule membrane prevents secretion of H+. It is important to administer potassium citrate continuously to improve blood pH, increase urinary citrate and reduce the risk of calcium phosphate crystallization.
Introduction
Distal renal tubular acidosis (dRTA) is a rare disease that affects fewer than 5 in 10,000 persons; therefore, it is not well studied [1] . The main defect is located in the distal nephron: it is unable to excrete protons (H+) because of a voltage-dependent defect in the membrane of the distal renal tubule. Further, dRTA is classified as primary or secondary. Primary dRTA may be associated with autosomal recessive neural deafness (gene mutation ATP6V1B1) or not associated with neural deafness (gene mutation ATP6V0A4). Secondary dRTA, which ocurrs more frequently, is associated with pyelonephritis, obstructive uropathy, hyperparathyroidism and other diseases [2, 3] . There are also two forms of clinical presentation. The complete form occurs during the infancy accompanied by vomiting, growth retardation, polyuria and dehydration that produces a hyperchloremic metabolic acidosis. The incomplete form usually occurs in adulthood with intermittent changes of pH, nephrocalcinosis and calcium phosphate stones that are produced by the increase in calciuria through hypercalcemia and phosphaturia [4, 5] . The diagnosis of dRTA is suggested by hyperchloremic metabolic acidosis with normal anion GAP, alkaline urine pH (greater than 6) and hypocitraturia, although further tests to are necessary to confirm the diagnosis [6] . An exhaustive knowledge of this pathology is required to control the symptoms, renal function and metabolic disorders of these patients.
Case report
A 73 year-old female patient presented at our unit 10 years ago with a right nephritic colic. An abdomen X-ray indicated severe bilateral nephrocalcinosis. At that time, a blood test performed showed the following results: urea, 45.6 mg/dl (normal, 10-50 mg/dl); creatinine, 2.1 mg/dl (normal, 0.5-1.2), potassium, 4.4 mEq/L (normal, 3.8-5.2 mEq/L), sodium, 143 mEq/L (normal, 135-148 mEq/L), chlorine, 105 mEq/L (normal, 95-110 mEq/L); pH, 7.25 (normal, 7.35-7.45); and urinary pH 6.5. In a blood test, iPTH, vitamin D, calcium and phosphorus showed normal values. Two of the most frequent causes of nephrocalcinosis are dRTA and hyperparathyroidism. As serum calcium and iPTH were normal, our initial diagnosis was dRTA because the patient presented metabolic acidosis with normal GAP anion and alkaline urine pH. As the diagnostic test for dRTA, the patient was given 10 g of oral bicarbonate and 500 mg of acetazolamide. After verifying the alkalinity of urine, the pCO2 in urine was 32 mmHg (normal, >70 mmHg), confirming a diagnosis of dRTA.
A 24-hour urine test showed a citrate value 55 mg/dl and calcium 12 mg/dl. Other studies included a diuretic renogram that revealed the right relative renal function, 91.2%, and left relative renal function, 8.8%; these values meant that the relative function of left kidney was greatly diminished by nephrocalcinosis, tubular damage and episodes of left ureteral obstruction that had hitherto gone unnoticed. The medical treatment established was potassium citrate, increased intake of liquids and strict follow-up of the patient. Finally, the patient's serum pH normalized to 7.35 and urinary citrate increased to 154 mg/dl. Other procedures included percutaneous right nephrostomy (Figure 1 ) and shock-wave lithotripsy on right ureteral lithiasis for calcium phosphate stones. In the course of the following years, the patient has excreted multiple lithiases, although the disease is controlled because she presents a normal pH with serum creatinine 1.5 mg/dl. After 10 years of an intensive treatment the patient retains stable renal function; she continues potassium citrate medication and undergoes strict follow-ups.
Treatment with potassium citrate was prescribed to alkalize serum pH and increase the urinary citrate because the patient had a diagnosis of severe nephrocalcinosis. If we had treated the patient with sodium bicarbonate, urinary sodium excretion would also have increased; therefore, we increased the urinary calcium excretion.
Discussion
Types of dRTA may be complete (urinary pH is continually above 5.5 and accompanied by metabolic acidosis) or incomplete (urinary pH higher than 5.5 with absence of metabolic acidosis). When this condition is diagnosed during childhood or puberty, primary is the most frequent type; in some cases, this disorder may affect other member of the family [7] . In adults, the principal clinical presentation is nephrolithiasis and nephrocalcinosis. In a patient with nephrocalcinosis, the differential diagnosis includes primary hyperoxaluria, familial hypomagnesemia and hypercalciuria, dRTA, hereditary hypophosphatemia Bartter syndrome and hyperparathyroidism [1, 7] . dRTA is characterized by increased urinary pH, decreased serum pH, decreased urine NH4+ and pCO2, hypercalciuria with hypocitraturia and the formation of calcium phosphate lithiasis. Struvite and calcium oxalate calculi also occur with relative frequency [8] . In general, dRTA diagnosis is based on clinical presentation and existence of metabolic disorders (metabolic acidosis, urine pH higher than 5.5 and hypocitraturia).
Several tests confirm the diagnosis of dRTA: Furosemide, which acidifies the urine under normal conditions, an effect that does not occur in this disease; an ammonium chloride test, which acidifies the urine under normal conditions, determinations must be made every 8 hours; a urine-blood pCO2 gradient. Also needed is a bicarbonate test in which the patient is given 2 mEq/ kg of bicarbonate and 500 mg of acetazolamide. The urine bicarbonate is measured 30 minutes after administration and if it is higher than 80 mEq/L urine, pCO2 should be measured (must be greater than 70 mmHg). A pCO2 lower than 70 mmHg confirms the diagnosis of dRTA [9] [10] [11] [12] . In our case, we performed the bicarbonate test showing a urine bicarbonate of 90 mEq/L after 30 minutes and a urine pCO2 of 32 mmHg. Treatment of this condition is based on the administration of alkalinizing agents that correct metabolic acidosis, including sodium bicarbonate or potassium citrate. Usually, in patients with dRTA but without nephrocalcinosis or nephrolithiasis, treatment with sodium bicarbonate can be prescribed (2 mEq/kg/day). However, because our patient presented with a significant lithiasic activity, we decided to administer potassium citrate. A percentage of potassium citrate is metabolized to bicarbonate, which increases the blood pH and raises the citrate in the urine without increasing calciuria. In some patients, instrumental treatment of stones is required using ureteroscopy, percutaneous nephrolithotomy or extracorporeal shock wave lithotripsy. In the present case, the most conservative techniques have been employed to preserve renal function, although a ureteral stent or percutaneous nephrostomy tube was necessary [13] .
We conclude that, according to our experience, it is crucial to perform an alkalizing treatment, an exhaustive clinical follow-up and also instrumental management when necessary.
